US 2017/0246218 A1 · OPHTHALMIC COMPOSITIONS

Abstract

The present invention discloses novel ophthalmic preparations for the treatment of corneal pathologies comprising umbilical cord blood plasma.

Dependent claims

A method for the treatment of corneal pathologies comprising the use of isolated umbilical cord blood plasma.

Dependencies are inferred from the claim text.

Facts

Application

15/517,094Filed 6 Oct 2015

Priority

IT MI2014A0017456 Oct 2014

Published

31 Aug 2017

Term ends

Not estimatedThe source records don’t support an estimate.

A61K 35/51
Reproductive organs: umbilical cord; Umbilical cord blood; Umbilical stem cells
A61K 38/1808
Growth factors; Growth regulators: epidermal growth factor [EGF] urogastrone
A61K 47/02
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…:…
A61K 47/12
Containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides: carboxylic acids; Salts or anhydrides thereof

The present invention discloses novel ophthalmic preparations for the treatment of corneal pathologies comprising umbilical cord blood plasma.